Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-018509

Chief Financial Officer sold 12,823 shares at $15.55 ($199,335)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2022-03-10 Sale −12,823 $15.55 $199,335 201,883 D: show line 1 in the form
Open-market sales · 12,823 sh · avg $15.55 · $199,335
Loading xslF345X03/doc4.xml…